The prevalence of hepatitis C virus infection in β-thalassemia patients in Pakistan: a systematic review and meta-analysis

BackgroundHepatitis C virus infection is the most commonly reported bloodborne infection in Pakistan. Frequent blood transfusions in beta -thalassemia patients expose them to a high risk of HCV infection. The purpose of this paper is to summarise the current data on the prevalence of HCV infection in beta -thalassemia patients in Pakistan by using a systematic review and meta-analysis.MethodsPubMed, EMBASE, Web of Sciences, the Cochrane Library, Directory of Open Access Journal and local databases were systematically searched for studies published between January 1st, 1995 and May 31st, 2019. Meta-analysis was performed using the DerSimonian and Laird random-effects models with inverse variance weighting. The presence of publication bias was tested by Egger test, and the methodological quality of each included article was evaluated by the STROBE.ResultsWe identified a total of 229 potential studies, of which 27 studies were finally considered in the meta-analysis. The pooled prevalence of HCV in beta -thalassemia patients in Pakistan was 36.21% (95% CI: 28.98-43.75%) based on 5789 beta -thalassemia patients, but there was considerable heterogeneity. Meta-analysis estimated the HCV prevalence among the beta -thalassemia patients at 45.98% (95% CI: 38.15-53.90%) in Punjab, 31.81% (95% CI: 20.27-44.59%) in Sindh, and 28.04% (95% CI: 13.58-45.26%) in Khyber Pakhtunkhwa. Meta-regression analysis showed that geographical location was a key source of heterogeneity.ConclusionsThe pooled prevalence of HCV in beta -thalassemia patients in Pakistan was more than one in three, and higher than in neighbouring countries. It varies regionally within the country. With the use of standard prevention procedures during blood transfusion, the risk of HCV transmission in beta -thalassemia patients could be controlled and the prevalence of HCV in beta -thalassemia patients reduced.